Report Detail
Global Anti Microbial Peptides Market Insights, Forecast to 2025
- RnM3525049 |
- 14 June, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
Global anti-microbial peptides market is segmented on the basis of peptides types such as plant anti-microbial peptides, bacterial anti-microbial peptides, animal anti-microbial peptides, insect anti-microbial peptides. Among these segments, animal and plant anti-microbial peptides are capturing the major share into the market as they are easy to extract as compared with other anti-microbial peptides. Researchers are also more inclined towards animal and plant anti-microbial peptides to observe and check under clinical trials.
Europe and North America are the leading regions in global anti-microbial peptide market owing to the large investment in R&D and healthcare industry. Europe anti-microbial peptides market valued USD 0.39 billion in 2016, and is projected to grow at a CAGR of 9.0% during the forecast period. There are approximately 45 peptides which are approved globally and are being used in different verticals out of which 5-6 are from Europe. European Union has announced to invest USD 1.7 billion to develop antimicrobial peptide drugs to tackle against drug-resistant bacteria. Europe was marketed for nearly 110 peptides in clinical trials and more than 150 peptides in advanced pre-clinical phase. Germany and the UK hold the major share of antimicrobial peptides market. Moreover, Greece is the largest and only producer of generic peptides of European Union.
The global Anti Microbial Peptides market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti Microbial Peptides market based on company, product type, end user and key regions.
This report studies the global market size of Anti Microbial Peptides in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti Microbial Peptides in these regions.
This research report categorizes the global Anti Microbial Peptides market by top players/brands, region, type and end user. This report also studies the global Anti Microbial Peptides market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AnaSpec
Novozymes
Bachem
Phoenix Biotech
AMP Biotech
Shanghai Abbiochem Company
Ramamoorthy Group
Lytix Biopharma
Ai2
Market size by Product
Plant Anti-Microbial Peptides
Bacterial Anti-Microbial Peptides
Animal Anti-Microbial Peptides
Insects Anti-Microbial Peptides
Market size by End User
Personal Care and Cosmetics Industry
Healthcare & Pharmaceuticals Industry
Biotechnology Industry
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Anti Microbial Peptides market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Anti Microbial Peptides market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Anti Microbial Peptides companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Anti Microbial Peptides submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Anti Microbial Peptides are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti Microbial Peptides market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Anti Microbial Peptides Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Anti Microbial Peptides Market Size Growth Rate by Product
- 1.4.2 Plant Anti-Microbial Peptides
- 1.4.3 Bacterial Anti-Microbial Peptides
- 1.4.4 Animal Anti-Microbial Peptides
- 1.4.5 Insects Anti-Microbial Peptides
- 1.5 Market by End User
- 1.5.1 Global Anti Microbial Peptides Market Size Growth Rate by End User
- 1.5.2 Personal Care and Cosmetics Industry
- 1.5.3 Healthcare & Pharmaceuticals Industry
- 1.5.4 Biotechnology Industry
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti Microbial Peptides Market Size
- 2.1.1 Global Anti Microbial Peptides Revenue 2014-2025
- 2.1.2 Global Anti Microbial Peptides Sales 2014-2025
- 2.2 Anti Microbial Peptides Growth Rate by Regions
- 2.2.1 Global Anti Microbial Peptides Sales by Regions
- 2.2.2 Global Anti Microbial Peptides Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Anti Microbial Peptides Sales by Manufacturers
- 3.1.1 Anti Microbial Peptides Sales by Manufacturers
- 3.1.2 Anti Microbial Peptides Sales Market Share by Manufacturers
- 3.1.3 Global Anti Microbial Peptides Market Concentration Ratio (CR5 and HHI)
- 3.2 Anti Microbial Peptides Revenue by Manufacturers
- 3.2.1 Anti Microbial Peptides Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti Microbial Peptides Revenue Share by Manufacturers (2014-2019)
- 3.3 Anti Microbial Peptides Price by Manufacturers
- 3.4 Anti Microbial Peptides Manufacturing Base Distribution, Product Types
- 3.4.1 Anti Microbial Peptides Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti Microbial Peptides Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti Microbial Peptides Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Anti Microbial Peptides Sales by Product
- 4.2 Global Anti Microbial Peptides Revenue by Product
- 4.3 Anti Microbial Peptides Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Anti Microbial Peptides Breakdown Data by End User
6 North America
- 6.1 North America Anti Microbial Peptides by Countries
- 6.1.1 North America Anti Microbial Peptides Sales by Countries
- 6.1.2 North America Anti Microbial Peptides Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Anti Microbial Peptides by Product
- 6.3 North America Anti Microbial Peptides by End User
7 Europe
- 7.1 Europe Anti Microbial Peptides by Countries
- 7.1.1 Europe Anti Microbial Peptides Sales by Countries
- 7.1.2 Europe Anti Microbial Peptides Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti Microbial Peptides by Product
- 7.3 Europe Anti Microbial Peptides by End User
8 Asia Pacific
- 8.1 Asia Pacific Anti Microbial Peptides by Countries
- 8.1.1 Asia Pacific Anti Microbial Peptides Sales by Countries
- 8.1.2 Asia Pacific Anti Microbial Peptides Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Anti Microbial Peptides by Product
- 8.3 Asia Pacific Anti Microbial Peptides by End User
9 Central & South America
- 9.1 Central & South America Anti Microbial Peptides by Countries
- 9.1.1 Central & South America Anti Microbial Peptides Sales by Countries
- 9.1.2 Central & South America Anti Microbial Peptides Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Anti Microbial Peptides by Product
- 9.3 Central & South America Anti Microbial Peptides by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Anti Microbial Peptides by Countries
- 10.1.1 Middle East and Africa Anti Microbial Peptides Sales by Countries
- 10.1.2 Middle East and Africa Anti Microbial Peptides Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Anti Microbial Peptides by Product
- 10.3 Middle East and Africa Anti Microbial Peptides by End User
11 Company Profiles
- 11.1 AnaSpec
- 11.1.1 AnaSpec Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AnaSpec Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AnaSpec Anti Microbial Peptides Products Offered
- 11.1.5 AnaSpec Recent Development
- 11.2 Novozymes
- 11.2.1 Novozymes Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novozymes Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novozymes Anti Microbial Peptides Products Offered
- 11.2.5 Novozymes Recent Development
- 11.3 Bachem
- 11.3.1 Bachem Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bachem Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bachem Anti Microbial Peptides Products Offered
- 11.3.5 Bachem Recent Development
- 11.4 Phoenix Biotech
- 11.4.1 Phoenix Biotech Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Phoenix Biotech Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Phoenix Biotech Anti Microbial Peptides Products Offered
- 11.4.5 Phoenix Biotech Recent Development
- 11.5 AMP Biotech
- 11.5.1 AMP Biotech Company Details
- 11.5.2 Company Business Overview
- 11.5.3 AMP Biotech Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 AMP Biotech Anti Microbial Peptides Products Offered
- 11.5.5 AMP Biotech Recent Development
- 11.6 Shanghai Abbiochem Company
- 11.6.1 Shanghai Abbiochem Company Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Shanghai Abbiochem Company Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Shanghai Abbiochem Company Anti Microbial Peptides Products Offered
- 11.6.5 Shanghai Abbiochem Company Recent Development
- 11.7 Ramamoorthy Group
- 11.7.1 Ramamoorthy Group Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Ramamoorthy Group Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Ramamoorthy Group Anti Microbial Peptides Products Offered
- 11.7.5 Ramamoorthy Group Recent Development
- 11.8 Lytix Biopharma
- 11.8.1 Lytix Biopharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Lytix Biopharma Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Lytix Biopharma Anti Microbial Peptides Products Offered
- 11.8.5 Lytix Biopharma Recent Development
- 11.9 Ai2
- 11.9.1 Ai2 Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Ai2 Anti Microbial Peptides Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Ai2 Anti Microbial Peptides Products Offered
- 11.9.5 Ai2 Recent Development
12 Future Forecast
- 12.1 Anti Microbial Peptides Market Forecast by Regions
- 12.1.1 Global Anti Microbial Peptides Sales Forecast by Regions 2019-2025
- 12.1.2 Global Anti Microbial Peptides Revenue Forecast by Regions 2019-2025
- 12.2 Anti Microbial Peptides Market Forecast by Product
- 12.2.1 Global Anti Microbial Peptides Sales Forecast by Product 2019-2025
- 12.2.2 Global Anti Microbial Peptides Revenue Forecast by Product 2019-2025
- 12.3 Anti Microbial Peptides Market Forecast by End User
- 12.4 North America Anti Microbial Peptides Forecast
- 12.5 Europe Anti Microbial Peptides Forecast
- 12.6 Asia Pacific Anti Microbial Peptides Forecast
- 12.7 Central & South America Anti Microbial Peptides Forecast
- 12.8 Middle East and Africa Anti Microbial Peptides Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti Microbial Peptides Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti Microbial Peptides. Industry analysis & Market Report on Anti Microbial Peptides is a syndicated market report, published as Global Anti Microbial Peptides Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Anti Microbial Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
